Daily FNArena News

The boards of Australia’s major banks survived their AGMs but a wider issue of proxy voting rights is playing out in the ESG sphere.

Ahead of the Herd’s Rick Mills explores the development of treatments for various medical conditions using illegal psychedelic drugs. Is LSD the new cannabis?

QBE Insurance expects reduced profitability in 2019 as a result of frost damage impacting on the North American crop in the second half.

The Chartist continues to believe in overall buyer interest in gold, but there remains a risk of a break-down.

Independent Investment Research updates developments in Australia’s listed investment trust and provides comparative data.

Brokers anticipate the acquisition of Church Community Builder by Pushpay Holdings will provide additional value and stabilise front book growth.

Peter Switzer of the Switzer Report outlines his expectations for the world and Australia in the next year.

Australian super funds undertaking ESG-based investment are outperforming the industry while ceding to growing demand from Australian investors.

Vehicle leasing and salary packaging business Smartgroup has succumbed to earnings pressure as its add-on insurance underwriter makes changes to product terms.

Sigma Healthcare has adjusted guidance to account for the renewed Chemist Warehouse contract, while Australian Pharmaceutical Industries finally takes its hat out of the merger ring.